早产儿贫血诊治研究进展  

Progress in the diagnosis and treatment of anemia in premature infants

作　　者：赵惠君[1] ZHAO Hui-jun(Department of Pediatrics,Suzhou Kowloon Hospital Shanghai Jiao Tong University School of Medicine,Suzhou 215003,Jiangsu Province,China)

机构地区：[1]上海交通大学医学院附属苏州九龙医院儿科,江苏苏州215003

出　　处：《世界临床药物》2020年第3期155-159,共5页World Clinical Drug

基　　金：苏州市科技局项目(SYSD2016055)。

摘　　要：早产儿贫血(anemia of prematurity,AOP)是新生儿期常见并发症之一,严重影响早产儿生存率和生存质量。红细胞输注是AOP临床常用的治疗方法,但输血存在较多风险,如可能诱发坏死性小肠结肠炎(necrotic enterocolon,NEC)、视网膜病变(retinopathy,ROP)和支气管肺发育不良(bronchopulmonary dysplasia,BPD)等严重并发症。因此,围产医学领域始终在探索安全、有效的早产儿贫血的防治疗法,并不断取得进展。本文归纳了近五年的相关文献,以供临床参考。Anemia of prematurity(AOP) is one of the common complications in neonatal period,which seriously affects the survival rate and quality of life of premature infants.Red blood cell transfusion is a common treatment for AOP,but there are many clinical risks in transfusion,such as necrotic enterocolitis(NEC),retinopathy(ROP),bronchopulmonary dysplasia(BPD) and other serious complications.Therefore,the field of perinatal medicine has always been exploring safe and effective prevention and treatment of anemia in premature infants,and has made continuous progress.This paper summarized the relevant literature in the past five years for the reference of clinical colleagues.

关 键 词：早产儿贫血 极低体质量儿 发病机制 促红细胞生成素 输血 

分 类 号：R722.6[医药卫生—儿科]